Study Title: Pharmacodynamic Biomarkers to Support Biosimilar Development: 
Clinical Study 2 (PCSK9 Inhibitors – Alirocumab and Evolocumab)  
 Document Title:  Clinical Study Protocol – Study No. SCR -007 
 
Document Date:  18 May 2020 
 
Study ID: [REMOVED] 
Digitally signed by [CONTACT_468779] -S 
DN: c=US, o=U.S. Government, ou=HHS, ou=FDA, ou=People, 
cn=David Strauss -S, 0.9.2342.19200300.100.1.1=[PHONE_9806] 
Date: 2020.06.07 14:58:51 -04'00'